In another promising development for cancer patients, Foundation Medicine announced this week that it has partnered with Epic to integrate Foundation’s genomic sequencing program with Epic’s electronic medical record (EMR) system. This collaboration represents an exciting step for AC/PMP and other cancer patients by facilitating physicians’ capability of ordering, receiving, and reviewing results of the genomic sequencing of a patient’s...

  Today marks the first day of September which is bittersweet, as our first ever dedicated awareness month of August has officially come to a close. While the month of August has ended, please remember that awareness can and should be all year long! Appendix cancer is a rare cancer but it deserves recognition, funding, and research so that our...

We are pleased to report of a promising development for appendix cancer patients with a tumor identified as having a mismatch repair deficiency (or “dMMR”). This week, FDA granted accelerated approval for a drug to treat recurrent or advanced solid tumors having a dMMR for which patients have no satisfactory treatment options. Specifically, FDA has granted approval to GlaxoSmithKline’s drug...

ACPMP is thrilled to announce that SUNDAY, August 15th, multiple bridges in Boston, Massachusetts and Minneapolis, Minnesota will be lit up in AMBER for Appendix Cancer Awareness Month! Boston, Massachusetts Zakim Bridge - Boston, MA Longfellow Bridge - Boston, MA Fore River Bridge - Quincy/Weymouth, MA Burns Bridge - Worcester, MA Minneapolis, Minnesota I-35W - Minneapolis, MN Lowry Ave Bridge...

The Appendix Cancer / Pseudomyxoma Peritonei Research Foundation (ACPMP), a 501(c)3 non-profit organization, is pleased to share that August is Appendix Cancer Awareness Month. Appendix cancer is a rare cancer diagnosed in approximately 3-4 people per million per year. Although appendix cancer is genetically distinct from colon cancer, like colon cancer the incidence of appendix cancer in the US is rising....

The WFORCE team has released a new article in the journal Clinical Cancer Research titled “Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study.” The goal of this study was to “preclinically explore the application of immunotherapy in treating appendix cancer in a personalized organoid model.” The study showed that “[i]nformation derived from immunocompetent organoids...

How to participate: You must be a member of Facebook. Click here to access the auction. Auction runs from Friday, June 11th through Monday, June 21st; bidding ends at 10am EDT. Comment on the item post with your bid (minimum bids are listed for each item); highest bigger when the auction closes wins the item. ACPMP will notify winner who will...

Vince Papale otherwise known as Mr. Invincible has some words for our community! Vince Papale, former Philadelphia Eagles walk-on legend, shares a message of support for the Appendix Cancer PMP Walk/Run, to be held virtually and in person Father's Day weekend, and the appendix cancer patient community. Sign up today for our Appendix Cancer PMP walk/run. Participate virtually in your...

The Appendix Cancer Pseudomyxoma Peritonei Research Foundation (ACPMP) is pleased to announce that Deborah Shelton will now serve as Executive Director.  Deborah began working with ACPMP as our Medical Liaison in late 2018 after her spouse was diagnosed with appendix cancer. Deborah’s addition to the team has been instrumental to ACPMP’s growth as she is able to leverage her 20+...

  It’s hard to believe this year marks the 15th annual Appendix Cancer/PMP Awareness Walk and Run. This event began on Father’s Day 2007, less than one year after the death of Frank “Dutch” Culbertson on July 22, 2006. As Father’s Day 2007 approached, Dutch’s wife Judy sought a positive way to commemorate the day with her children. She and...